M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY – Get Free Report) has been given a consensus recommendation of “Hold” by the six analysts that are covering the company, Marketbeat reports. Five analysts have rated the stock with a hold recommendation and one has given a strong buy recommendation to the company.
Several equities research analysts have recently weighed in on MURGY shares. Hsbc Global Res raised M�nchener R�ckversicherungs-Gesellschaft to a “hold” rating in a research note on Monday, April 28th. Keefe, Bruyette & Woods lowered M�nchener R�ckversicherungs-Gesellschaft from a “hold” rating to a “moderate sell” rating in a report on Friday, June 6th. Finally, The Goldman Sachs Group lowered M�nchener R�ckversicherungs-Gesellschaft from a “strong-buy” rating to a “hold” rating in a report on Monday, March 24th.
View Our Latest Research Report on MURGY
M�nchener R�ckversicherungs-Gesellschaft Stock Up 2.1%
M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY – Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The financial services provider reported $0.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.71. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $19.09 billion. M�nchener R�ckversicherungs-Gesellschaft had a return on equity of 14.53% and a net margin of 7.53%. As a group, research analysts predict that M�nchener R�ckversicherungs-Gesellschaft will post 0.46 earnings per share for the current year.
M�nchener R�ckversicherungs-Gesellschaft Company Profile
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.
Featured Articles
- Five stocks we like better than M�nchener R�ckversicherungs-Gesellschaft
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- Find and Profitably Trade Stocks at 52-Week Lows
- Overheated Market? Analysts Watch These Red Flags
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for M�nchener R�ckversicherungs-Gesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M�nchener R�ckversicherungs-Gesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.